EODData

MEMBERSHIP REGISTER LOG IN

FRA, BIX0: BIOINVENT INTERN. SK 2

23 Oct 2026
LAST:

1.798

CHANGE:
 0.00		OPEN:
1.798		HIGH:
1.798		ASK:
0.000		VOLUME:
0
CHG(%):
0.00		PREV:
1.798		LOW:
1.798		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Oct 261.7981.7981.7981.7980
22 Oct 261.7981.7981.7981.7980
21 Oct 261.8901.8901.8901.8900
20 Oct 261.8941.8941.8941.8940
19 Oct 262.0552.0552.0552.055783
16 Oct 262.0552.0552.0552.0550
15 Oct 262.0552.0552.0552.0550
13 Oct 262.0102.0102.0102.0100
12 Oct 262.0202.0202.0202.0200
09 Oct 262.0102.0102.0102.0100

PROFILE

Name:BIOINVENT INTERN. SK 2
About:BioInvent International AB (publ), a clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally. The company's drug candidates include BI-1808, an anti- tumor necrosis factor receptor-2 (TNFR2) antibody in Phase 2a trial for the treatment of solid tumors and a type of blood cancer; BI-1206, an anti-FcyRIIB antibody in Phase 1/2a trial for the treatment of non-Hodgkin's lymphoma, as well as Phase 1/2a trial to treat advanced solid tumors; BI-1910, an anti-TNFR2 antibody in Phase 1/2a clinical trial to treat solid tumors; BI-1607, an anti-FcyRIIB antibody in Phase 1b/2a clinical trial to treat solid tumors; and BT-001, an anti- cytotoxic T lymphocyte-associated protein-4 (CTLA-4) antibody in Phase 1 clinical trial for the treatment of solid tumors. It has a partnership and collaboration with Transgene to develop BT-001 oncolytic viruses for treatment of solid tumors; collaboration and supply agreement with MSD to evaluate BI-1808, BI-1910, BI-1206, BI-1607, and BT-001 in combination with Keytruda; and licensing agreement with CASI Pharmaceuticals to develop BI-1206 in both hematological and solid cancers. BioInvent International AB (publ) was incorporated in 1996 and is based in Lund, Sweden.
Sector:Healthcare
Industry:Biotechnology
Address:The Gamma Building, Lund, Sweden, 223 70
Website:https://www.bioinvent.com
ISIN:SE0015244520

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.40 
PEG Ratio:-0.07 
Price to Sales:0.58 
Price to Book:0.19 
Profit Margin:-1.54 
Operating Margin:-1.47 
Return on Assets:-0.48 
Return on Equity:-0.88 
Revenue:226.5M 
Shares:65.8M 
Market Cap:118.32M 

TECHNICAL INDICATORS

MA5:1.894.9%
MA10:1.968.9%
MA20:1.958.7%
MA50:2.0111.7%
MA100:2.1318.6%
MA200:2.2323.8%
RSI14:32.94 
WPR14:-100.00 
MTM14:-0.18
ROC14:-0.09 
ATR:0.03 
Week High:2.0614.3%
Week Low:1.800.0%
Month High:2.0614.3%
Month Low:1.8023.8%
Year High:3.2178.5%
Year Low:1.800.0%
Volatility:15.90 

RECENT SPLITS

Date Ratio
14 Dec 20201-25